Carregant...
DDIS-03. HARNESSING siRNA NANOMEDICINE FOR THERAPEUTIC GENE SILENCING IN GLIOBLASTOMA
GBM is the most common primary brain tumor in adults, with a very poor prognosis. Despite tremendous efforts to develop new drugs, the treatment of GBM remains a great challenge. The use of nanoparticles (NPs) has emerged as a potential strategy for diagnosis and treatment of tumors, GBM especially....
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692115/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.239 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|